SCHEMBL32672056

SCHEMBL32672056

Cc1cnc(NC(=O)Oc2ccccc2)cn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.52
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
TDP1 Q9NUW8 2/20 0.49
CCNE1 P24864 1/20 0.49
CDK2 P24941 1/20 0.49
CDK5 Q00535 1/20 0.49
ALDH1A1 P00352 6/20 0.49
MAPT P10636 2/20 0.49
MAPKAPK2 P49137 1/20 0.46
PORCN Q9H237 1/20 0.46
KDM4E B2RXH2 1/20 0.46
THRB P10828 1/20 0.46
GFER P55789 1/20 0.46
GAA P10253 3/20 0.45
HTT P42858 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL305046 1.00 NOTUM (0.52) NOTUMMEN1KMT2ATDP1CCNE1
SCHEMBL27785448 0.85 KMT2A (0.47) NOTUMMEN1KMT2ATDP1CCNE1
SCHEMBL2595570 0.83 CCNE1 (0.47) MEN1KMT2ATDP1CCNE1CDK2
SCHEMBL1011423 0.82 ALDH1A1 (0.50) MEN1KMT2ATDP1CCNE1CDK2
SCHEMBL31028805 0.82 ALDH1A1 (0.50) MEN1KMT2ATDP1CCNE1CDK2
SCHEMBL5788823 0.82 RAB9A (0.58) MEN1KMT2ACCNE1CDK2CDK5
SCHEMBL16775794 0.81 RAB9A (0.49) MEN1KMT2ATDP1CCNE1CDK2
SCHEMBL1009480 0.81 CCNE1 (0.45) MEN1KMT2ACCNE1CDK2CDK5
SCHEMBL18058629 0.81 CCNE1 (0.48) NOTUMMEN1KMT2ATDP1CCNE1
SCHEMBL32672176 0.80 FAAH (0.45) MEN1KMT2ATDP1CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630562-B2 Piperidylurea compounds and methods of use thereof ARCUS BIOSCIENCES, INC. (US) 2026-05-19 US disclosed
US-20260042777-A1 PIPERIDYLUREA COMPOUNDS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2026-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630562-B2 Piperidylurea compounds and methods of use thereof CLIC1, HCCS, CNR1 NOTUM 3578/4885MEN1 2043/4885KMT2A 2998/4885
US-20260042777-A1 PIPERIDYLUREA COMPOUNDS AND METHODS OF USE THEREOF CBR1, CLIC1, RER1 NOTUM 4086/4885MEN1 2352/4885KMT2A 2802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.